Alzheimer's Partnerships: Sharing Risks, Chasing Potentially Huge Rewards

Even now, decades after the first scientifically informed hypotheses about what causes Alzheimer's disease (AD), no consensus and thus no clear path towards treatment exists. Offsetting the uncertainty is the knowledge that a truly effective treatment would be a smashing success - potentially generating double-digit billions in annual global revenues